Assignee
LINEAGE CELL THERAPEUTICS INC
US·3 granted patents·11 pending applications·0 citations·filing 2016–2025
Top patents by PatentIndex Score
14 records- 0164US2021102251A1Methods for telomere length and genomic dna quality control analysis in pluripotent stem cellsLINEAGE CELL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0262US10920191B2Methods of screening embryonic progenitor cell linesLINEAGE CELL THERAPEUTICS INC·Filed 2017·Granted Feb 16, 2021·0 cites·6 claims
- 0362US10745752B2Methods for telomere length and genomic DNA quality control analysis in pluripotent stem cellsLINEAGE CELL THERAPEUTICS INC·Filed 2016·Granted Aug 18, 2020·0 cites·11 claims
- 0458US2026002126A1Methods for differentiating pluripotent stem cells in dynamic suspension cultureLINEAGE CELL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0558US2023086868A1Methods and compositions for treating retinal diseases and conditionsLINEAGE CELL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0658US2025057886A1Methods and compositions for treating hearing lossLINEAGE CELL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0756US2022168361A1Methods for measuring therapeutic effects of retinal disease therapiesLINEAGE CELL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0852US2024158745A1Methods of generating oligodendrocyte progenitor cells and use thereofLINEAGE CELL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0951US12365872B2Methods for differentiating pluripotent stem cells in dynamic suspension cultureLINEAGE CELL THERAPEUTICS INC·Filed 2019·Granted Jul 22, 2025·0 cites·15 claims
- 1049US2024299625A1Methods and compositions for treating retinal diseases and conditionsLINEAGE CELL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1149US2023313127A1Compositions and methods for embryonic stem cell expansionLINEAGE CELL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1246US2023134801A1Mhc restricted immunogenic telomerase reverse transcriptase -specific peptides, their complex conjugates, and methods of using the sameLINEAGE CELL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1346US2022354896A1Compositions and methods for the treatment of retinal degenerationLINEAGE CELL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1439US2021155895A1Pluripotent Stem Cell-Derived 3D Retinal Tissue and Uses ThereofLINEAGE CELL THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LINEAGE CELL THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →